| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amarin Corp Plc\uk (AMRN) has 5 insiders with recent SEC Form 4 filings, including 1 buy and 13 sells. AMRN is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 80.7K | $1.28M | - | |
| COO | 9.7K | $154.3K | - | |
| CFO | 6.4K | $102.3K | - | |
| VP | 3.7K | $58.6K | - | |
| VP | 2.2K | $35.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2018 | Kennedy Joseph T | General Counsel | Sale+OE | 44,857 | $3.73 | $167,388.38 | -70.9% | |
| Jan 23, 2018 | Ketchum Steven B | Chief Scientific Officer | Sale+OE | 135,205 | $4.41 | $596,429.82 | -48.8% | |
| Jan 17, 2018 | Kennedy Joseph T | General Counsel | Sell | 51,106 | $4.10 | $209,449.80 | -41.2% | |
| Jan 11, 2018 | Ketchum Steven B | Chief Scientific Officer | Sale+OE | 2,612 | $4.40 | $11,492.80 | -1.8% | |
| Jan 5, 2018 | Ketchum Steven B | Chief Scientific Officer | Sale+OE | 64,683 | $4.40 | $284,631.07 | -31.3% | |
| Jan 2, 2018 | Ketchum Steven B | Chief Scientific Officer | Sale+OE | 128,257 | $4.25 | $545,092.25 | -47.5% | |
| Nov 30, 2017 | Thero John F | President And CEO | Buy | 10,000 | $3.24 | $32,446.00 | +0.9% | |
| Oct 5, 2017 | Ketchum Steven B | Chief Scientific Officer | Sell | 63,479 | $3.48 | $221,198.92 | -30.9% | |
| Jul 3, 2017 | Kennedy Joseph T | General Counsel | Sale+OE | 307,911 | $4.00 | $1,230,932.80 | -62.9% | |
| Nov 9, 2016 | Kennedy Joseph T | General Counsel | Sell | 122,358 | $3.04 | $372,041.73 | -43.0% |